$11.00 0.00 (0%)
7/6/2010 5:33 PM

SenoRx, Inc. (NASDAQ:SENO)

CAPS Rating: 1 out of 5

The Company develops, manufactures and sells minimally-invasive medical devices for the diagnosis of breast cancer.

Recs

0
Player Avatar janvandebong (93.49) Submitted: 1/3/2008 12:35:24 PM : Outperform Start Price: $8.50 SENO Score: +31.97

I wouldn't buy it, I like p/e ratios too much - but I could see this becoming an intuitive surgical-type stock eventually. It's growing, paying off debt, & this price seems to be a reasonable jumping off point.

Report this Post Add Comment

Featured Broker Partners


Advertisement